TB antibodies is sold as "research" only not "sales" on table as yet.
Under this agreement, NeoClone will pay all costs associated with the manufacture, marketing and distribution of the antibodies, "which will be sold for research uses only".
Dr Jenny Harry, said “We are delighted to appoint NeoClone as the preferred provider of Tyrian’s TB antibodies for "research purposes".
This is disclose in the announcement
CGA Price at posting:
0.2¢ Sentiment: None Disclosure: Not Held